Scaling Radioligand Therapy: 3 Essential Strategies From Inside The Ecosystem

Success requires orchestrating an end-to-end experience that connects manufacturing, logistics, clinical sites, payers, and patients seamlessly. The companies that treat this orchestration as a strategic competency, rather than just operational logistics, will be best positioned to scale. The post Scaling Radioligand Therapy: 3 Essential Strategies From Inside The Ecosystem appeared first on MedCity News.

Read More

Life sciences companies falling behind?

That is what an analysis from PwC finds, at least with respect to stock market returns. Our PwC equal-weight index of 50 pharma companies analyzes the sector’s total shareholder returns performance relative to the S&P 500 Equal Weighted Index. From 2018 through November 2024, the PwC pharma index returned 7.6% to shareholders, compared with more…

Read More